Daniela Bursacovschi

Dr. Daniela Bursacovschi

orcid

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 December 2025 in Biomedicines
Verified
Journal Article
Open access
PDF file
DBDaniela Bursacovschi
Daniela Bursacovschi
AAArnaut Arnaut
Arnaut Arnaut
VOViorica Ochisor
Viorica Ochisor
GMGeorgeta Mihalache
Georgeta Mihalache
RBRuslan Baltaga
Ruslan Baltaga
VRValeriu Revenco
Valeriu Revenco
Background/Objectives: Cancer Therapy-Related Cardiac Dysfunction (CTRCD) is a major complication in patients with non-Hodgkin lymphoma (NHL), potentially leading to heart failure and other severe cardiovascular events. Early identification of patients at risk is crucial for timely interventions. Methods: A prospective analytical cohort study was conducted on 127 adult NHL patients to evaluate chemotherapy-related cardiac dysfunction over a 6-month period, with the aim of assessing early adverse cardiac effects. Assessments included echocardiography, cardiorespiratory exercise testing, 24-h Holter monitoring, and measurement of cardiac-specific biomarkers (troponin I and NT-proBNP) to identify early subclinical cardiac changes. Results: A predictive model for CTRCD was developed using clinical, serological, echocardiographic, cardiopulmonary, and treatment-related parameters in patients with non-Hodgkin lymphoma. The model demonstrated high overall accuracy (94.2%) and strong discriminative ability (AUC 0.95; precision-sensitivity AUC 0.824) for 6-month cardiotoxicity. SHAP analysis identified the most influential predictors as baseline SDNNi, mean daily heart rate, total doxorubicin dose, NT-proBNP, QT corrected interval, hemoglobin, age, left atrial volume, and diastolic function indices (E/e′, E/A). Lower cardiopulmonary reserve was also associated with increased risk. Conclusions: The predictive model developed in this study serves as a practical and robust tool for assessing the risk of cancer therapy-related cardiac dysfunction.

1 October 2025
Verified
Journal Article
Open access
PDF file
MAMarcel Abras
Marcel Abras
EPEcaterina Pasat
Ecaterina Pasat
ASArtiom Surev
Artiom Surev
IGInesa Gutan
Inesa Gutan
VMVitalie Moscalu
Vitalie Moscalu
DGDaniela Goian
Daniela Goian
Introduction. Aortic stenosis is the most common valvular disease among elderly patients and carries a poor prognosis if left untreated. Transcatheter aortic valve implantation (TAVI) has emerged as an effective alternative to surgical valve replacement, particularly in high- and intermediate-risk patients. The type of valve implanted may significantly influence postoperative outcomes. Aim of study. To assess the efficacy and safety of TAVI based on the type of prosthesis used: self-expanding (SEV) versus balloon-expandable (BEV). Materials and Methods. A prospective study was conducted on 114 patients over 70 years old with severe aortic stenosis who underwent TAVI: Abbott valve (n=44), Medtronic (n=40), Edwards (n=30). Valve performance and safety were evaluated according to Valve Academic Research Consortium-3 (VARC-3) criteria. Results. No significant differences were observed between groups regarding age, BMI, sex, or comorbidities. Edwards valves showed the highest post-TAVI mean pressure gradients (16.2 ± 6.7 mmHg), followed by Abbott (12.4 ± 6 mmHg) and Medtronic (10.1 ± 3.5 mmHg, pless than 0.001). Vmax was significantly higher in the Edwards group at all followups (pless than 0.01), indicating greater residual stenosis risk. Left ventricular function was similar across groups. Paravalvular regurgitation was more frequent with Edwards (pless than 0.001 vs. Abbott, p=0.008 vs. Medtronic). High-grade AV block and permanent pacemaker implantation were more frequent in the SEV group. Mortality and rehospitalization rates were similar between groups. Conclusions. TAVI proved to be an effective and safe treatment for severe aortic stenosis in elderly patients. The type of prosthesis influences hemodynamic performance and complication profile, highlighting the need for individualized valve selection based on patient characteristics.

1 September 2025 in Moldovan Journal of Health Sciences
Verified
Journal Article
Closed access
MAMarcel Abras
Marcel Abras
EPEcaterina Pasat
Ecaterina Pasat
MVMaria-Magdalena Vicol
Maria-Magdalena Vicol
CCCatalina Ciorici
Catalina Ciorici
DBDaniela Bursacovschi
Daniela Bursacovschi
Introduction. Severe aortic stenosis and ischemic coronary artery disease are frequently associated in elderly patients, adding complexity to interventional management. Diastolic dysfunction, a marker of myocardial impairment and elevated filling pressures, may influence prognosis after transcatheter aortic valve implantation (TAVI), particularly in the presence of concomitant coronary pathology. The aim of the study was to analyze the interaction between severe aortic valve stenosis, left ventricular diastolic dysfunction, and coronary ischemia in elderly patients with complex cardiovascular disease. Material and methods. This was a prospective analytical cohort study including 85 patients treated between 2019 and 2023, divided into two groups: Group I - TAVI without coronary intervention (n = 56), and Group II - TAVI associated with percutaneous coronary intervention (PCI) (n = 29), consisting of patients with significant coronary lesions. Echocardiography was performed according to the ESC/EACVI 2016 guideline standards, with detailed assessment of diastolic function. Results. The prevalence of left ventricular diastolic dysfunction of varying severity showed a statistically significant difference between groups (p = 0.04): Group I - 35 patients (62.5%) versus Group II - 24 patients (82.7%). The E-wave velocity was lower in Group II: 152.4 cm/sec (IQR = 43.0) compared to 173.0 cm/sec (IQR = 32.0), p = 0.01. The E/A ratio and the incidence of E/A ≥2 showed a borderline significant difference (p = 0.04). Median E/e′ was higher in Group II - 9.2 (IQR = 5.4) compared to 6.4 (IQR = 4.2), p = 0.003. E/Vp was 1.2 (IQR = 0.4) versus 0.8 (IQR = 0.5), p less than 0.001. Diastolic dysfunction was more frequent in Group II, with significantly different echocardiographic parameters, including decreased E-wave velocity, increased E/e′ and E/Vp ratios, and a higher incidence of E/A ≥2. Conclusions. Patients undergoing both PCI and TAVI more frequently exhibited left ventricular diastolic dysfunction. The echocardiographic parameters E, E/e′, and E/Vp showed statistically significant differences, suggesting an additive impact of coronary artery disease on diastolic function impairment in the setting of severe aortic stenosis.

3 June 2026 in Diagnostics
Verified
Journal Article
Open access
PDF file
MAMarcel Abras
Marcel Abras
DBDaniela Bursacovschi
Daniela Bursacovschi
EPEcaterina Pasat
Ecaterina Pasat
MVMaria-Magdalena Vicol
Maria-Magdalena Vicol
TATatiana Abras
Tatiana Abras
AAArnaut Arnaut
Arnaut Arnaut
Background/Objectives: Permanent pacemaker implantation (PPI) remains one of the most common complications following transcatheter aortic valve replacement (TAVR). Identifying patients at increased risk for post-procedural conduction disturbances is clinically important for procedural planning and patient management. The aim of this study was to develop and evaluate a machine learning-based model for predicting the risk of PPI after TAVR. Methods: This prospective study was conducted between 2019 and 2025, and included 179 patients with severe aortic stenosis who underwent TAVR. Patient eligibility was determined by a multidisciplinary Heart Team based on clinical, echocardiographic, and imaging criteria. The primary endpoint was PPI occurring during hospitalization or within 30 days after the procedure. Statistical analyses were performed using RStudio (v. 2024.09.1+394)and Python (v.3.12.3), including comparative tests for continuous and categorical variables, receiver operating characteristic analysis to assess model performance, and SHapley Additive exPlanations (SHAP) to evaluate feature importance and model interpretability. Results: A total of 179 patients undergoing TAVR were included in the analysis. PPI occurred in 17 patients (9.5%) within 30 days after the procedure. A machine learning model was developed to predict post-TAVR PPI. The model demonstrated good predictive performance, with an overall accuracy of 0.944 and a weighted F1-score of 0.947. The confusion matrix showed that the model correctly classified 155 patients without PPI and 14 patients with PPI, with only a small number of false predictions. Explainability analyses using SHAP and permutation feature importance revealed that anatomical and procedural variables had the greatest impact on model predictions. The most influential predictors included valve size, right coronary sinus diameter, prosthetic valve diameter, and mean aortic annulus diameter. In contrast, baseline clinical variables such as left ventricular ejection fraction, previous myocardial infarction, and mean transaortic gradient showed a comparatively lower contribution to the prediction of PPI after TAVR. Conclusions: This study demonstrates that machine learning models can effectively predict the risk of PPI after TAVR. Anatomical characteristics of the aortic root and prosthesis-related parameters were the main determinants of PPI, whereas baseline clinical variables had a lower impact. The use of explainable artificial intelligence methods, such as SHAP analysis, may improve risk stratification and support procedural planning in patients undergoing TAVR.

1 June 2023 in Bulletin of the Academy of Sciences of Moldova. Medical Sciences
Verified
Journal Article
Open access
PDF file
DBDaniela Bursacovschi
Daniela Bursacovschi
The paper presents a summary of the literature that includes the results of the research on the echocardiographic parameters for the early detection and monitoring of the cardiac toxicity of the antitumor treatment. While the left ventricular ejection fraction is currently the most widely used index to quantify cardiac function in cardio-oncology, there are a number of indices under investigation to prove their prognostic value in the occurrence of adverse cardiac events during cancer therapy. Such indices derived from the Doppler method, speckle tracking parameters, strain rate as well as parameters derived from three-dimensional echocardiography, which can provide additional sensitivity and substantial prognostic value for future cardiovascular events.

13 January 2025 in Preprints.org
Verified
Preprint
Open access
PDF file
DBDaniela Bursacovschi
Daniela Bursacovschi
VRValeriu Revenco
Valeriu Revenco
MRMaria Robu
Maria Robu
AAArnaut Arnaut
Arnaut Arnaut
Background: Non-Hodgkin lymphoma (NHL) is associated with significant cardiovascular risks due to treatment-related toxicities, including cancer therapy-related cardiac dysfunction (CTRCD). While multimodality imaging, particularly echocardiography, is pivotal in monitoring cardiac function, the prognostic role of cardiopulmonary exercise testing (CPET) in predicting CTRCD remains underexplored. Methods: This prospective study included 127 patients with NHL assessed before initiating antitumor treatment and at six months follow-up using echocardiography and cardiopulmonary exercise testing. Results: Our found that asymptomatic CTRCD occurred in 14.2% of NHL patients at six months of treatment. Patients with CTRCD exhibited significantly lower median work rates, volume of oxygen (VO₂) at the anaerobic threshold, and O₂ consumption efficiency, reflecting compromised metabolic and functional performance. Baseline peak oxygen consumption (VO₂ peak) positively correlated with left ventricle ejection fraction (LVEF) at six months, while VO₂ peak < 14 ml/kg/min was negatively associated with LVEF. Conclusions: Asymptomatic CTRCD was identified in 14.2% of NHL patients at six months, with lower work rates, VO₂ at the anaerobic threshold, and O₂ consumption efficiency indicating impaired performance. Baseline peak oxygen consumption correlated positively with LVEF, highlighting CPET's potential for early CTRCD risk assessment.